Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 14;12(2):57-64.
doi: 10.9740/mhc.2022.04.057. eCollection 2022 Apr.

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements

Richard J Silvia  1   2   3   4   5   6 , Kelly C Lee  1   2   3   4   5   6 , Gregory H Payne  2 , Jessica Ho  3 , Carla Cobb  4 , Elayne D Ansara  5 , Clint A Ross  6
Affiliations

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements

Richard J Silvia et al. Ment Health Clin. .

Abstract

Introduction: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements for a best practice model for OPPs providing direct patient care.

Methods: Board Certified Psychiatric Pharmacists and American Association of Psychiatric Pharmacists (AAPP) members were questioned using a 5-phase (P1-P5) survey and summit approach. The phases were: P1, broad ideation survey; P2, 10-person summit to develop draft statements; P3, survey of the draft statements for acceptance; P4, summit to resolve review feedback; and P5, survey of AAPP membership to confirm the finalized statements.

Results: P1 survey results generated a list of 143 possible attributes that informed the P2 summit, which were refined to 28 statements. P3 survey results confirmed at least 70% agreement with each statement. The P4 summit evaluated all P3 survey results and made significant modifications to 4 statements. Informal feedback was sought with other stakeholders, and supporting narratives and references were developed to provide clarity regarding the intent of each statement. Finalized statements and supporting narratives were confirmed in the P5 survey.

Discussion: The 28 attribute statements were developed over 18 months by gathering input and consensus through multiple modalities, including 3 surveys, 2 summit meetings, and numerous informal feedback requests. The agreement on the attribute statements was consistently high across all phases. The final attribute statements are presented elsewhere in this issue.

Keywords: attributes; best practice; consensus; outpatient; psychiatric pharmacy.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Phases in statement development (AAPP = American Association of Psychiatric Pharmacists; OPPPS = Outpatient Psychiatric Pharmacy Practice Summit)
FIGURE 2
FIGURE 2
Initial survey questions (phase 1)
See this image and copyright information in PMC

References

    1. Stimmel GL. Psychiatric pharmacy. Am J Health Syst Pharm. 2013;70(4):366–7. 10.2146/ajhp120504 PubMed PMID: 23370144. - DOI - PubMed
    1. Stoner SC, Ott CA, DiPaula BA. Psychiatric pharmacy residency training. Am J Pharm Educ. 2010;74(9):163. 10.5688/aj7409163 PubMed PMID: 21301597. - DOI - PMC - PubMed
    1. Silvia RJ, Lee KC, Bostwick JR, Cobb CD, Goldstone LW, Moore TD, et al. Assessment of the current practice of psychiatric pharmacists in the United States. Ment Health Clin [Internet] 2020;10(6):346–53. 10.9740/mhc.2020.11.346 PubMed PMID: 33224692 PubMed Central PMCID: PMC7653732. - DOI - PMC - PubMed
    1. Werremeyer A, Bostwick J, Cobb C, Moore TD, Park SH, Price C, et al. Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin [Internet] 2020;10(6):358–80. 10.9740/mhc.2020.11.358 PubMed PMID: 33224694 PubMed Central PMCID: PMC7653731. - DOI - PMC - PubMed
    1. World Health Organization [Internet] Decision-making for guideline development at WHO. WHO handbook for guideline development 2nd ed; 2014 (cited 2022 Mar; pp 20114 online) In. Available from: https://apps.who.int/iris/handle/10665/145714.